Form 8-K - Current report:
SEC Accession No. 0000950170-25-069254
Filing Date
2025-05-12
Accepted
2025-05-12 16:18:14
Documents
13
Period of Report
2025-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20250512.htm   iXBRL 8-K 45392
2 EX-99.1 prok-ex99_1.htm EX-99.1 315019
3 GRAPHIC img22993735_0.jpg GRAPHIC 34636
  Complete submission text file 0000950170-25-069254.txt   543413

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20250512.xsd EX-101.SCH 25828
15 EXTRACTED XBRL INSTANCE DOCUMENT prok-20250512_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 25935132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)